Background and Purpose-Our aim was to study the effect of drainage of cortical veins, including the superficial middle cerebral vein (SMCV), vein of Trolard, and vein of Labbé on neurological outcomes after reperfusion therapy. Methods-Consecutive ischemic stroke patients who underwent pretreatment computed tomographic perfusion and 24-hour computed tomographic perfusion or magnetic resonance perfusion after intravenous thrombolysis were included. We defined "absent filling of ipsilateral cortical vein" (eg, SMCV−) as no contrast filling of the vein across the whole venous phase on 4-dimensional computed tomographic angiography in the ischemic hemisphere. Results-Of 228 patients, SMCV−, vein of Trolard− and vein of Labbé− were observed in 50 (21.9%), 27 (11.8%), and 32 (14.0%) patients, respectively. Only SMCV− independently predicted poor outcome (3-month modified Rankin Scale score of >2; odds ratio, 2.710; P=0.040). No difference was found in reperfusion rate after treatment between patients with and without SMCV− (P>0.05). In patients achieving major reperfusion (≥80%), there was no difference in 24-hour infarct volume, or rate of poor outcome between patients with and without SMCV− (P>0.05). However, in those without major reperfusion, patients with SMCV− had larger 24-hour infarct volume (P=0.011), higher rate of poor outcome (P=0.012), and death (P=0.032) compared with those with SMCV filling. SMCV− was significantly associated with brain edema at 24 hours (P=0.037), which, in turn, was associated with poor 3-month outcome (P=0.002). 
S
troke pathophysiology is related not only to responses in neuronal tissue but also to the vascular neural network, composed of upstream arteries, arterioles, capillaries and downstream venules and veins. 1 The venous compartment is responsible for 70% to 80% of the circulatory volume inside the cranial cavity. In the setting of acute ischemic stroke (AIS), animal studies have shown that microthrombi in venules are present within 30 minutes after acute reduction of cerebral blood flow (CBF). 2 Moreover, the absence of cerebral venous flow draining the ischemic region was associated with increased severity of hemiparesis and larger infarct volume. 3 These findings support a view that the cerebral veins play a vital role in the maintenance of CBF and brain function after ischemia. However, most current neuroradiological assessments primarily focus on cerebral arterial circulation/ perfusion status, whereas prognostic information on cerebral venous outflow on AIS is rare.
Recently, the importance of the venous drainage pattern has been described in AIS. The PRECISE (Prognostic Evaluation on Cortical Vein Score Difference in Stroke) score, assessed on single-phase CT angiography (CTA), was shown to predict poor outcome in patients with a proximal arterial occlusion of the anterior circulation. 4 With time-resolved dynamic CTA, a combined assessment of extent and velocity of cortical venous filling had additional prognostic value over established predictors of outcome. 5 These studies highlighted that cerebral venous drainage provided additional prognostic information in AIS, but the mechanism of how poor venous outflow relates to worse outcome was not addressed. Furthermore, these earlier methods could not objectively reflect the distribution of cortical venous filling, as they focused on the opacification of all vessels presented at venous phase, when cortical veins could be confused with late-filling retrograde-flow arterial collaterals.
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Thus, the aim of this study was to investigate the impact of cortical venous filling on neurological outcome during the process of ischemia-reperfusion, and the potential mechanisms behind poor venous and adverse stroke outcome. We hypothesized that the lack of venous filling may have an effect on the subsequent development of brain edema, and we were also interested in exploring if quality of venous filling had an effect on subsequent reperfusion.
Subjects and Methods
Ethics Statement
Written informed consent was obtained from each patient or an appropriate family member. The local human ethics committee approved the protocol of this study (no. 2011-018). All clinical investigations were conducted according to the principles expressed in the Declaration of Helsinki.
Study Subjects
We reviewed our consecutively collected patients with AIS who received intravenous thrombolysis (IVT) between June 2011 and November 2015. We then enrolled patients who (1) received IVT within 6 hours after onset; (2) underwent computed tomographic perfusion (CTP) before IVT, and CTP or magnetic resonance perfusion at 24 hours after IVT; (3) had follow-up modified Rankin Scale (mRS) score at 3 months; and (4) had prestroke mRS score of ≤2. Intravenous recombinant tissue-type plasminogen activator was administered according to the international guidelines.
We retrieved demographic, clinical, laboratory, and radiological data including age, sex; comorbid conditions such as history of hypertension, diabetes mellitus, and atrial fibrillation; time from onset to imaging; NIHSS (National Institutes of Health Stroke Scale) score; and mRS score after 3 months. Patients were dichotomized into good (mRS score of ≤2) versus poor outcome (mRS score of >2) at 90 days.
Imaging Protocols
All patients underwent baseline CTP, including noncontrast CT (NCCT) and volume perfusion CT, and 24 hours CTP or magnetic resonance perfusion in accordance with our routine stroke imaging protocol. 7 The effective dose (calculated by multiplying dose-length products with published conversion factors) amounted to 3.68 mSV for volume perfusion CT and 2.19 mSV for NCCT acquisition. All images were reconstructed using commercial software (MIStar; Apollo Medical Imaging Technology, Melbourne, Australia). Volume perfusion CT images were reconstructed to obtain T max map and fourdimensional (4D) CTA images, presented in axial, coronal and sagittal planes with 20-mm-thick maximum intensity projection.
Image Analysis
The ASPECTS (Alberta Stroke Program Early CT Score) was assessed by a neuroradiologist (X.D.) to detect early ischemic changes on pretreatment NCCT. 8 A threshold of T max >6 s was used for the volumetric measurement of pretreatment and 24-hour hypoperfusion areas. 9 Pretreatment relative CBF (rCBF) <30% was used for calculating ischemic core volume, 10 and 24-hour DWI or NCCT for final infarct volume. 11 Hemorrhagic transformation was classified as hemorrhagic infarction and parenchymal hemorrhage, according to the ECASS definition. Symptomatic intracranial hemorrhage was defined as any intracranial hemorrhage associated with an increase of ≥4 points on NIHSS, or leading to death.
12
Definition of Absent Filling of Ipsilateral Cortical Veins
Arterial input function and venous output function (VOF) were automatically selected by the software MIStar from middle cerebral artery/anterior cerebral artery and superior sagittal sinus of nonischemic hemisphere, respectively. According to the VOF curve, the venous peak phase was identified and selected to reconstruct the single-phase 3D CT venography (3D CTV) by the software NeuroDSA (Siemens, Munich, Germany).
On the basis of this 3D CTV (Movie I in the online-only Data Supplement), three veins, including the superficial middle cerebral vein (SMCV), vein of Trolard (VOT), and vein of Labbé (VOL), in each hemisphere were separately assessed. The principles for identifying these three cortical veins including (1) SMCV, VOT, and VOL are the largest cortical veins; (2) as SMCV, VOT, and VOL join the sphenoparietal sinus, superior sagittal sinus and transverse sinus, respectively, these three cortical veins on sagittal view are visualized as claws stretching out from the left, top and right side of brain surface. When the three veins meet, they form a "Y" structure ( Figure 1A) ; (3) because of the difficult differentiation of VOT from other ascending anastomosis, we set three steps to better identify the presence of VOT if it was not obvious: (1) find the corresponding vein within the ipsilateral hemisphere with reference to the contralateral VOT, (2) find the vein that has similar luminal diameter to SMCV or VOL, 13 and (3) check the level of post central vein on the superior sagittal sinus where the dominant VOT is presented in most cases.
14 Therefore, the presence of the targeted cortical vein (marked as SMCV+/VOT+/VOL+) was first confirmed on 3D CTV, which was defined as the appearance of contrast flow in the targeted cortical vein. We then reassessed the cortical veins on 4D CTA reconstructed from CTP, if there was absent or obscure contrast filling in the targeted cortical vein. As Figure 1 shows, on 4D CTA, the presence of contrast filling of the targeted cortical vein at any time point of venous phase were still defined as SMCV+/VOT+/VOL+, whereas the absence of ipsilateral cortical veins (marked as SMCV−/VOT−/ VOL−) was defined as no contrast filling of the targeted cortical vein across the whole venous phase in the ischemic hemisphere. The absence of the targeted cortical vein in nonstroke patients and the comparison between venous anatomy in stroke and nonstroke patients are described in the study I in the online-only Data Supplement.
The two raters (S.Z. and Y.L.) who jointly evaluated the images of veins were blinded to the patients' other imaging and clinical data. A single trained observer (S.Z.) measured the veins of all patients twice, at an interval of 3 months apart. Another observer (Y.L.) independently made the same evaluation.
During the tracking process for each vein on 4D CTA, the software allowed raters to simultaneously identify if hypoperfusion (T max >6 s) was distributed within the drainage area of the targeted vein ( Figure 2 ), based on previous literature. 13 Accordingly, patients were dichotomized into 2 groups: hypoperfusion within or outside the drainage territories of the targeted vein. Patients with hypoperfusion area within the drainage territory of the targeted vein were classified as the matched group, while the others with hypoperfusion area outside the drainage territory of the targeted vein as the unmatched group.
Reperfusion and Brain Edema
Reperfusion rate=(baseline hypoperfusion volume−24-hour hypoperfusion volume)/baseline hypoperfusion volume. On the basis of reperfusion rate, we defined 2 patient groups: major reperfusion (≥80%) and no major reperfusion (<80%). 15 In the major reperfusion group, we defined ratio of penumbra tissue salvage as: (baseline hypoperfusion volume−final infarct volume)/(baseline hypoperfusion volume−baseline ischemic core volume). 16 In the no major reperfusion group, penumbra tissue loss ratio was defined as: (final infarct volume−baseline ischemic core volume)/(baseline hypoperfusion volume−baseline ischemic core volume). 17 Brain edema was assessed by a stroke neurologist (Y.L.) and a neuroradiologist (X.D.) independently by grading hemispheric swelling on a 7-point scale at baseline NCCT and 24 hours NCCT or DWI. 18, 19 Brain edema expansion was defined as an increase in grade from baseline to 24 hours after IVT.
Statistical Analysis
Metric and normally distributed variables were reported as mean±standard deviation; non-normally distributed variables as median (25th-75th percentile). Categorical variables were presented as frequency (percentage). Kappa statistics were used to test inter-and intrarater reliability for detecting the presence of each cortical vein and the degree of baseline and 24-hour brain edema. Comparisons between groups were assessed with Student's t test for parametric data, Mann-Whitney U test for nonparametric data, and Pearson χ 2 test for categorical data. Spearman correlation coefficient was used to analyze the associations among radiological and clinical variables. Independent factors for the absent filling of each cortical vein, poor outcome, and reperfusion were evaluated using binary logistic regression analysis, respectively. A P value of <0.05 was considered to be statistically significant. Statistical analyses were conducted using SPSS, version 19.0 (IBM, Armonk, NY).
Results
Overall Characteristics
There were 247 patients who met the inclusion criteria, with 228 patients included in the final analysis after 4 patients with incomplete imaging data and 15 patients with inadequate quality of postprocessed images for the assessment of venous drainage were excluded. The median age was 69 years (interquartile range 59-78 years), with 85 (37.3%) being women. The median baseline NIHSS was 10 (interquartile range 5-15), and median onset to needle time (ONT) was 198 minutes (interquartile range 133-270 minutes). Twenty-three (10.1%) patients received mechanical thrombectomy. Poor outcome occurred in 107 (46.9%) patients, 21 (9.2%) patients died, 52 (22.8%) patients had hemorrhagic transformation, and 11 (4.8%) patients had symptomatic intracranial hemorrhage.
Excellent inter-and intraobserver reliability was seen in distinguishing the presence of SMCV− (κ=0.856 and 0.973), VOT− (κ=0.795 and 0.903), and VOL− (κ=0.727 and 0.935). The occurrence of SMCV−, VOT−, and VOL− were found in 50 (21.9%), 27 (11.8%), and 32 (14.0%) patients in ischemic hemisphere, respectively, while they were found in 9 (3.9%), 3 (1.3%), and 6 (2.6%) patients in the nonischemic hemisphere, respectively. 
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Relationship Between Venous Filling and Neurological Outcome
In the unmatched group of SMCV, no significant difference of the rate of poor outcome was observed between ipsilateral SMCV+ and SMCV− ( Change in venous filling after treatment could be evaluated in 55 patients with 24-hour CTP. We found that baseline ipsilateral SMCV− was more likely to be reversed to SMCV+ at 24 hours in patients with reperfusion, compared with those without reperfusion (87.5% versus 33.3%, χ 2 =4.381, P=0.036). In contrast, no patient with baseline SMCV+ deteriorated to SMCV− at 24 hours, even in the absence of major reperfusion. However, SMCV− patients that reversed to SMCV+ at 24 hours showed no lower rate of poor outcome in comparison 
The Different Impact of Venous Filling on Outcome Based on Reperfusion Status
We did subgroup analysis based on reperfusion status. In patients with no reperfusion, ipsilateral SMCV− patients had higher rates of poor outcome (OR, 11.302; 95% CI, 1.153-110.819; P=0.037), and larger 24-hour infarct volume (P=0.011) and death (P=0.032), compared with SMCV+ patients (Table 2) . However, in patients with reperfusion, no significant difference was found in outcome between ipsilateral SMCV+ and SMCV− patients (P=0.247).
The Impact of Venous Filling on Penumbral Evolution
We found similar penumbral salvage ratio (P=0.913) in the reperfusion group and penumbral loss ratio (P=0.215) in the no reperfusion group between patients with ipsilateral SMCV+ and SMCV− ( Table 2) . Venous filling did not seem to have an influence on penumbral evolution.
The Impact of Venous Filling on Brain Edema
Excellent inter-and intraobserver reliability was seen in assessing the degree of baseline (κ=0.868, κ=0.827) and 24-hour brain edema (κ=0.859, κ=0.846).
As Figure 3 shows, in patients without major reperfusion, brain edema expansion within 24 SMCV− was significantly associated with brain edema expansion at 24 hours (ρ=0.256, P=0.037), which, in turn, was associated with poor outcome (ρ=0.379, P=0.002).
Discussion
The primary finding of this study is that the absent filling of the SMCV in the ischemic hemisphere independently predicted poor outcome after reperfusion therapy in patients with AIS, and, its mechanism appeared because of the development of brain edema at 24 hours, particularly in the absence of major reperfusion.
Our result supports the independent impact of SMCV drainage pattern on outcome, which is consistent with a previous finding that the occlusion of SMCV was the most important factor contributing to morbidity in patients undergoing pterional approach for aneurysm surgery. 20 However, it differs from previous finding, which demonstrated that the lack of all three veins, SMCV, VOT, and VOL filling, was related to poor outcome. 4 This variance may be attributed to the assessment of dynamic CTA in this study, which clearly improves the sensitivity for delayed contrast arrival in vessels, compared with conventional single-phase CTA. 21 Thus, late-filling cortical veins overlooked by conventional CTA could be detected by dynamic CTA. This is supported by the finding that rates of absent filling of cortical veins (SMCV, 22.4%; VOT, 11.8%; and VOL, 14.0%) were much lower than those detected by conventional CTA (SMCV, 59%; VOT, 38.5%; and VOL, 46.2%). Moreover, the anatomic features of veins may further explain the impact variance of three cortical veins on functional outcome. Compared with SMCV, less motor 
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functional regions are involved in the drainage area of VOL. Moreover, previous studies also proved that the resection or thrombosis of VOL in epilepsy surgery might not be related to subsequent infarction or poor outcome. 22, 23 Meanwhile, the drainage of VOT can be compensated by abundant superior anastomotic veins, which initiate the recruitment of venous collateral pathways.
Brain edema expansion was the key mechanism that linked SMCV− with poor outcome. The underlying pathophysiological mechanism of the development of brain edema is probably due to elevated venous pressure (Figure 4 ). Due to microthrombotic occlusion in venules, the subsequent resistance to cerebrospinal fluid absorption will result in the elevation of venous pressure, which may increase fluid leakage into the perivascular space, resulting in brain edema. 24 Furthermore, the exacerbation of cytotoxic edema that occurs early after acute cerebral venous thrombosis may also be a factor in our study, and could potentially explain the large 24-hour edema volume in patients with SMCV−. 25 In addition, injury of the insula, which is drained by SMCV, may also contribute to the expansion of brain edema in patients with SMCV−, as the insula plays a crucial role in the regulation of autonomic function. 26 Previous studies have shown that insular ischemia was associated with impaired baroreflex sensitivity and was found to be involved in the formation of fatal brain edema. 27 This anatomic feature of SMCV may also partially explain the impact of variance between SMCV and the other two cortical veins on functional outcome.
Interestingly, our finding relating brain edema due to the absent filling of ipsilateral SMCV is different from previous studies, where cortical venous injury generally resulted in hemorrhage. 13 This discrepancy may reflect that the veinmediated pathophysiology in AIS is likely to be caused by an imbalance between arterial inflow and venous outflow. Constant arterial inflow with damaged venous outflow may lead to neurovasular injury with subsequent hemorrhage, whereas reduced arterial inflow with venous outflow dysfunction would tend to develop brain edema.
In this study, absent filling of ipsilateral SMCV was associated with the volume of baseline hypoperfusion. We further found that timely reperfusion lowered the rate of poor outcome (and of brain edema) and was able to restore venous filling. These findings strongly suggest that venous outflow is influenced by the severity of reduction in arterial flow and refutes the view that the lack of venous filling purely relates to the compression of venules by brain edema after cerebral ischemia. 28 Experimental studies in vein occlusion models demonstrated that the growth of the venous thrombi coincided with decrease in regional CBF. 29 After arterial reperfusion, the obstructed lumina of venules might reopen, with venous microemboli being cleared from the microcirculation within 2 hours after reperfusion. 30 It is, thus, reasonable to infer that the change of venous flow represents a combined dynamic result of the extent of both initial ischemia and arterial reperfusion.
Conversely, absent filling of SMCV did not affect the rate of reperfusion or the effect of successful reperfusion on penumbra salvage. This is consistent with the concept that the venule is a crucial contributor to cerebrovascular resistance, but its role in the regulation of flow is minimal under physiological conditions. 31 Improvement in antegrade CBF or arterial collateral flow appear to be the main mechanisms leading to early reperfusion. In this study, we did not validate the absent filling of cortical veins on CTP by digital subtraction angiography for patients who received endovascular therapy as a superselective catheterization of the target occluded artery was used during surgery for saving the onset-reperfusion time. However, we found that the interrater agreement for the identification of the absent filling of three cortical veins were excellent, indicating that it was feasible to assess cortical veins on CTP in patients with AIS. A recent study also published that the interrater agreement was high in assessing the velocity and extent of cortical venous filling using CTP-derived 4D CTA, 5 supporting that CTP is reliable to depict venous outflow and may be a better way to assess the drainage status of cortical veins.
Other limitations in this study include a retrospective design and a potential risk of selection bias. However, the use of consecutive patients with AIS in our prospective registry with highly homogenous and standardized treatment regimen might have minimized this problem. Second, the use of both CT and magnetic resonance imaging as follow-up imaging might result in heterogeneity of volume measurement, but it may not affect our results because the distribution of followup CT or magnetic resonance imaging were almost identical between SMCV− and SMCV+ patients. Third, there is a certain proportion of the congenital absence of cortical veins in healthy population, our study did not evaluate whether this has any impact on neurological outcome. We specifically focused on hypoperfusion within the drainage territories of the targeted veins and its relationship with absent venous filling.
Finally, the sample size was modest and was performed retrospectively. The benefit for SMCV− patients that reversed to SMCV+ at 24 hours from aggressive reperfusion therapy should be confirmed and extended in larger sample size, randomized prospective clinical trials in future.
In conclusion, this is the first study to systematically examine the relationship between venous filling of major cortical veins and arterial perfusion after AIS. The absent filling of ipsilateral SMCV was strongly related to severe hypoperfusion, and reperfusion was able to refill the absent SMCV, while the status of venous filling itself had no influence on the occurrence of reperfusion. Through the expansion of brain edema, the absent filling of ipsilateral SMCV was associated with poor outcome after IVT, especially when reperfusion was not achieved. Therefore, successful revascularization still should be the primary goal for AIS, and patients with absent filling of ipsilateral SMCV would appear to benefit most from reperfusion therapy. The clinical implications of these results are that SMCV− patients should undergo more aggressive reperfusion strategies (eg, thrombectomy) as their outcomes in the absence of reperfusion are poor. 
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